Expression of stem cell marker and receptor kinase genes in glioblastoma tissue quantified by real-time RT-PCR

Brain Tumor Pathology

Volumn 28, Issue 4, 2011, Pages 291-296

  Yoshimoto, Koji ^a   Ma, Xinlong ^a   Guan, Yaulei ^a   Mizoguchi, Masahiro ^a   Nakamizo, Akira ^a   Amano, Toshiyuki ^a   Hata, Nobuhiro ^a   Kuga, Daisuke ^a   Sasaki, Tomio ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Glioma; Quantification; Stem cell marker

Indexed keywords

BMI1 PROTEIN; CD133 ANTIGEN; CELL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; NESTIN; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE KINASE; STEM CELL MARKER; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3; BIOLOGICAL MARKER;

ARTICLE; BMI 1 GENE; CD133 GENE; CLINICAL ARTICLE; EGFR GENE; ERBB4 GENE; FGFR1 GENE; FGFR2 GENE; GENE; GENE CLUSTER; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MELK GENE; NESTIN GENE; NOTCH1 GENE; NOTCH2 GENE; NOTCH3 GENE; NOTCH4 GENE; NUCLEOTIDE SEQUENCE; PDGFRA GENE; PDGFRB GENE; QUANTITATIVE ANALYSIS; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VEGFR1 GENE; VEGFR2 GENE; VEGFR3 GENE; ADULT; BRAIN TUMOR; CANCER STEM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84857065790     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-011-0046-0     Document Type: Article

References (25)

1. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (Lond) 455: 1061-1068
2. Rich JN, Bigner DD (2004) Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3: 430-446 (Pubitemid 38618125)
3. Mellinghoff IK, Wang MY, Vivanco I et al (2005) Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 353: 2012-2024 (Pubitemid 41609094)
4. Nicolis SK (2007) Cancer stem cells and ''stemness'' genes in neuro-oncology. Neurobiol Dis 25: 217-229 (Pubitemid 46124005)
5. Zeppernick F, Ahmadi R, Campos B et al (2008) Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129 (Pubitemid 351377986)
6. Ma YH, Mentlein R, Knerlich F et al (2008) Expression of stem cell markers in human astrocytomas of different WHO grades. J Neuro-oncol 86: 31-45 (Pubitemid 350263430)
7. Dell'Albani P (2008) Stem cell markers in gliomas. Neurochem Res 33: 2407-2415
8. Natsume A, Kinjo S, Yuki K et al (2011) Glioma-initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol 28: 1-12
9. Strojnik T, Rosland GV, Sakariassen PO et al (2007) Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68: 133-143 (Pubitemid 47087905)
10. Nakano I, Paucar AA, Bajpai R et al (2005) Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J Cell Biol 170: 413-427 (Pubitemid 41126941)
11. Nakano I, Masterman-Smith M, Saigusa K et al (2008) Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J Neurosci Res 86: 48-60
12. Facchino S, Abdouh M, Chatoo W et al (2010) BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery. J Neurosci 30: 10096-10111
13. Kanamori M, Kawaguchi T, Nigro JM et al (2007) Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 106: 417-427 (Pubitemid 46354295)
14. Stockhausen MT, Kristoffersen K, Poulsen HS (2010) The functional role of Notch signaling in human gliomas. Neurooncology 12: 199-211
15. Marie SK, Okamoto OK, Uno M et al (2008) Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer 122: 807-815
16. Dunn IF, Heese O, Black PM (2000) Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neuro-oncol 50: 121-137 (Pubitemid 32169649)
17. Mentlein R, Forstreuter F, Mehdorn HM et al (2004) Functional significance of vascular endothelial growth factor receptor expression on human glioma cells. J Neuro-oncol 67: 9-18 (Pubitemid 38418244)
18. Huang H, Held-Feindt J, Buhl R et al (2005) Expression of VEGF and its receptors in different brain tumors. Neurol Res 27: 371-377 (Pubitemid 40734696)
19. Furnari FB, Fenton T, Bachoo RM et al (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710 (Pubitemid 350070717)
20. Zhang M, Song T, Yang L et al (2008) Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27: 85
21. Xu P, Yu S, Jiang R et al (2009) Differential expression of Notch family members in astrocytomas and medulloblastomas. Pathol Oncol Res 15: 703-710
22. Abdouh M, Facchino S, Chatoo W et al (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29: 8884-8896
23. Phillips HS, Kharbanda S, Chen R et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173 (Pubitemid 43357943)
24. Brennan C, Momota H, Hambardzumyan D et al (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4: e7752
25. Verhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110